podcast.de
Anmeldung
Anmeldung Registrierung
Auto Hell Dunkel
Erweiterte Suche
  1. Startseite
  2. Podcasts
  3. Medizin - Open Access LMU - Teil 15/22 Podcast
  4. Bench-to-bedside review: Latest results in hemorrhagic shock
Hemorrhagic shock is a leading cause of death in trauma patients
worldwide. Bleeding control, maintenance of tissue oxygenation with
fluid resuscitation, coagulation support, and maintenance of
normothermia remain mainstays of therapy for patients with
hemorrhagic shock. Although now widely practised as standard in the
USA and Europe, shock resuscitation strategies involving blood
replacement and fluid volume loading to regain tissue perfusion and
oxygenation vary between trauma centers; the primary cause of this
is the scarcity of published evidence and lack of randomized
controlled clinical trials. Despite enormous efforts to improve
outcomes after severe hemorrhage, novel strategies based on
experimental data have not resulted in profound changes in
treatment philosophy. Recent clinical and experimental studies
indicated the important influences of sex and genetics on
pathophysiological mechanisms after hemorrhage. Those findings
might provide one explanation why several promising experimental
approaches have failed in the clinical arena. In this respect, more
clinically relevant animal models should be used to investigate
pathophysiology and novel treatment approaches. This review points
out new therapeutic strategies, namely immunomodulation,
cardiovascular maintenance, small volume resuscitation, and so on,
that have been introduced in clinics or are in the process of being
transferred from bench to bedside. Control of hemorrhage in the
earliest phases of care, recognition and monitoring of individual
risk factors, and therapeutic modulation of the inflammatory immune
response will probably constitute the next generation of therapy in
hemorrhagic shock. Further randomized controlled multicenter
clinical trials are needed that utilize standardized criteria for
enrolling patients, but existing ethical requirements must be
maintained.

Weitere Episoden

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

vor 17 Jahren
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

vor 17 Jahren
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

vor 17 Jahren
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

vor 17 Jahren
Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

vor 17 Jahren
Alle Episoden anzeigen
In Podcasts werben
Schalte jetzt Werbung in Podcasts.
Episode melden

„Bench-to-bedside review: Latest results in hemorrhagic shock“

Worum geht es? Danach fragen wir noch nach dem Grund.

Abonnenten

Teilen

Mein Archiv

Deine Privatkopie der Folgen, die du nicht verlieren willst.

Podcast-Folgen verschwinden. Feeds werden auf die letzten Episoden gekürzt, Hoster räumen alte Dateien ab, Formate wechseln den Anbieter und lassen ihr Archiv zurück. Mit „Mein Archiv“ sichert podcast.de die Folgen deiner Podcasts für dich — angefangen bei den ältesten, denn die sind zuerst weg.

  • Deine gesicherten Folgen bleiben hörbar, auch wenn das Original offline geht.
  • Auch Folgen, die im heutigen Feed gar nicht mehr stehen — podcast.de kennt sie noch.
  • Herunterladen bleibt möglich, solange die Folge beim Podcaster liegt. Der zählt seine Abrufe wie bisher.
Startet bald

Sei beim Start von Mein Archiv dabei

Mein Archiv ist fast fertig. Trag dich ein, dann bekommst du eine E-Mail, sobald es losgeht – und bist von Anfang an dabei. Wir schreiben dir nur zum Start, keine Werbung, keine Weitergabe deiner Daten.

Du bekommst zuerst eine Bestätigungsmail. Abmelden geht jederzeit. Datenschutz